Orthofix Medical Inc. income statement
In fiscal 2025, Orthofix Medical Inc. reported revenue of $822m, up 2.9% on the year before, operating income of −$81.4m (a -9.9% margin) and net income of −$92.2m, or −$2.33 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 546 | 463 | 436 | 440 | 398 | 402 | 396 | 410 | 434 | 453 | 460 | 407 | 464 | 461 | 747 | 799 | 822 | 833 |
| Cost of revenue | 138 | 97 | 96 | 101 | 107 | 99 | 87 | 88 | 93 | 97 | 101 | 102 | 115 | 124 | 260 | 254 | 256 | 239 |
| Gross profit | 407 | 365 | 339 | 339 | 291 | 303 | 310 | 322 | 341 | 356 | 359 | 305 | 350 | 337 | 486 | 546 | 566 | 594 |
| Research and development | 31 | 28 | 23 | 29 | 27 | 25 | 26 | 29 | 30 | 33 | 35 | 39 | 50 | 49 | 80 | 74 | 66 | 61 |
| Selling, general and administrative | — | — | — | — | — | — | — | — | — | — | — | — | — | 309 | 530 | 533 | 554 | 558 |
| Selling and marketing | 216 | 196 | 185 | 179 | 175 | 167 | 178 | 181 | 198 | 206 | 224 | 204 | 221 | — | — | — | — | — |
| General and administrative | 89 | 73 | 65 | 54 | 68 | 79 | 87 | 76 | 72 | 83 | 86 | 68 | 69 | — | — | — | — | — |
| Operating income | 64 | 66 | 7 | 75 | −11 | 17 | 9 | 21 | 41 | 30 | −19 | −6 | −8 | −13 | −139 | −85 | −81 | −39 |
| Interest expense | 25 | 11 | 5 | 4 | 2 | 2 | — | — | — | — | — | — | — | — | — | — | — | — |
| Net interest income | — | — | — | — | −2 | −2 | −0 | 1 | −0 | −1 | −0 | −2 | −2 | −1 | −9 | −30 | −17 | −21 |
| Provision for credit losses | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 2 | 1 | 2 | 2 | 4 |
| Income before tax | 40 | 55 | −1 | 69 | −11 | 12 | 9 | 19 | 36 | 23 | −27 | −0 | −13 | −18 | −149 | −124 | −91 | −60 |
| Income tax | 16 | −6 | 14 | 24 | 8 | 16 | 11 | 16 | 29 | 9 | 1 | −3 | 25 | 2 | 3 | 2 | 1 | 1 |
| Net income | 24 | 44 | −18 | 43 | −29 | −9 | −3 | 3 | 6 | 14 | −28 | 3 | −38 | −20 | −151 | −126 | −92 | −62 |
| Diluted EPS | $1.42 | $2.47 | −$0.97 | $2.21 | −$1.54 | −$0.46 | −$0.15 | $0.17 | $0.34 | $0.72 | −$1.51 | $0.13 | −$1.95 | −$0.98 | −$4.12 | −$3.30 | −$2.33 | −$1.53 |
| Diluted shares (average) | 17m | 18m | 18m | 19m | 19m | 18m | 19m | 18m | 18m | 19m | 19m | 19m | 20m | 20m | 37m | 38m | 40m | 40m |
| EBITDA | 86 | 88 | 30 | 93 | 12 | 40 | 30 | 42 | 61 | 49 | 6 | 24 | 21 | 16 | −86 | −25 | −4 | 14 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 197 | 216 | 194 | 203 | 206 | 220 | 197 | 211 |
| Cost of revenue | 62 | 67 | 72 | 64 | 57 | 64 | 57 | 61 |
| Gross profit | 135 | 149 | 122 | 140 | 149 | 156 | 140 | 150 |
| Research and development | 17 | 19 | 20 | 16 | 15 | 15 | 15 | 16 |
| Selling, general and administrative | 130 | 136 | 133 | 136 | 148 | 137 | 135 | 138 |
| Operating income | −19 | −11 | −49 | −16 | −17 | 0 | −14 | −8 |
| Net interest income | −5 | −15 | −5 | −4 | −5 | −4 | −6 | −6 |
| Provision for credit losses | 0 | −0 | 1 | 1 | 1 | −0 | 1 | 3 |
| Income before tax | −27 | −30 | −52 | −14 | −22 | −2 | −21 | −15 |
| Income tax | 1 | −1 | 1 | −0 | 1 | 0 | 0 | 1 |
| Net income | −27 | −29 | −53 | −14 | −23 | −2 | −21 | −16 |
| Diluted EPS | −$0.71 | −$0.75 | −$1.35 | −$0.36 | −$0.57 | −$0.05 | −$0.52 | −$0.39 |
| EBITDA | −4 | 5 | −14 | 1 | −4 | 14 | −1 | 5 |
Compare with peers
- Alphatec Holdings, Inc. income statement
- Irhythm Holdings, Inc. income statement
- Myriad Genetics Inc income statement
- Varex Imaging Corp income statement
- Inspire Medical Systems, Inc. income statement
Head to head: ATEC vs OFIXIRTC vs OFIXMYGN vs OFIXOFIX vs VREX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies